Ping Chen
University of Science and Technology of China(CN)Central South University(CN)Shandong University(CN)Changsha Medical University(CN)Dalian Institute of Chemical Physics(CN)Yantai University(CN)Chinese Academy of Sciences(CN)Hefei Institutes of Physical Science(CN)Wuhan University(CN)Hunan Provincial Center for Disease Control and Prevention(CN)Shanghai Medical Information Center(CN)Taichung Veterans General Hospital(TW)Zhongnan Hospital of Wuhan University(CN)United States Army Institute of Surgical Research(US)Suzhou Research Institute(CN)General Hospital of Shenyang Military Region(CN)First Hospital of China Medical University(CN)Tea Research Institute(CN)Beijing Tsinghua Chang Gung Hospital(CN)Second Xiangya Hospital of Central South University(CN)Shenzhen Genoimmune Medical Institute(CN)University of Chinese Academy of Sciences(CN)China Medical University(CN)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases, Neonatal Respiratory Health Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Prevalence of Chronic Obstructive Pulmonary Disease in China(2007)760 cited
- → Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial(2023)555 cited
- → Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study(2008)354 cited
- → Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial(2014)249 cited
- → A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation(2020)230 cited
- → Multifaceted role of prohibitin in cell survival and apoptosis(2015)